Log In
BCIQ
Print this Print this
 

Recombinant anti-CD20 mAb

  Manage Alerts
Collapse Summary General Information
Company Shanghai Pharmaceuticals Holding Co. Ltd.
DescriptionRecombinant humanized anti-CD20 mAb injection
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentIND
Standard Indication Inflammation (unspecified)
Indication DetailsTreat inflammation
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today